Company Sansure Biotech Inc.

Equities

688289

CNE1000043J1

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

EPS Revisions

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 25/04/2024 BST			5-day change	1st Jan Change
19.07 ^CNY	+1.44%		+3.70%	-2.46%

02-29	Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%	MT
02-28	Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Sansure Biotech Inc is a company mainly engaged in research and development, production and sales of diagnostic reagents and instruments. The Company's diagnostic reagent products are comprised of viral hepatitis series, reproductive tract infection and genetic series, pediatric infection series and nucleic acid blood screening series. The instrument products include automatic nucleic acid detection reaction system construction series and fluorescent polymerase chain reaction (PCR) monitoring and analysis software. The Company also provides related inspection services, including medical inspection and scientific research services which are provided for medical institutions.

Number of employees: 2,567

CNY in Million	2022	Weight	2023	Weight	Delta
Diagnostic Reagent 77.8 %	4,299	66.7 %	783	77.8 %	-81.78%
Diagnostic Instrument 14.7 %	1,764	27.3 %	148	14.7 %	-91.59%
Detection Service 5.9 %	235	3.7 %	60	5.9 %	-74.70%
Other Business 1.6 %	147	2.3 %	16	1.6 %	-89.07%

CNY in Million	2022	Weight	2023	Weight	Delta
China 93.0 %	5,870	93.1 %	922	93.0 %	-84.30%
Overseas 7.0 %	433	6.9 %	69	7.0 %	-84.00%

Managers	Title	Age	Since
Li Zhong Dai CEO	Chief Executive Officer	56	22/04/08
Wu Tan CHM	Chairman	40	31/12/09
Zhu Peng DFI	Director of Finance/CFO	48	31/07/17
Jia Liu BRD	Director/Board Member	42	31/12/08
Xu Fan BRD	Director/Board Member	43	31/12/07
Xia Lin Yu BRD	Director/Board Member	45	30/11/08
Zhong Ping Deng PRN	Corporate Officer/Principal	47	30/11/18

Members of the board	Title	Age	Since
Shan Ping Wang BRD	Director/Board Member	60	30/06/16
Li Zhong Dai CEO	Chief Executive Officer	56	22/04/08
Xia Lin Yu BRD	Director/Board Member	45	30/11/08
Zhu Peng DFI	Director of Finance/CFO	48	31/07/17
Yuan Fang BRD	Director/Board Member	41	31/01/19
Wu Tan CHM	Chairman	40	31/12/09
Xu Fan BRD	Director/Board Member	43	31/12/07
Jia Liu BRD	Director/Board Member	42	31/12/08
Chao Jun Xiao BRD	Director/Board Member	58	17/07/22
Lang Feng BRD	Director/Board Member	39	17/07/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	604,710,880	280,229,676 ( 46.34 %)	16,251,077 ( 2.687 %)	46.34 %

Name	Equities	%	Valuation
Li Zhong Dai 38.62 %	227,238,944	38.62 %	607 M ¥
Wen Yi Chen 5.594 %	32,917,370	5.594 %	88 M ¥
Jin Wei Zhu 5.000 %	29,423,069	5.000 %	79 M ¥
Anhui Zhidao Investment Co. Ltd. 3.096 %	18,218,572	3.096 %	49 M ¥
SANSURE BIOTECH INC. 1.671 %	9,835,793	1.671 %	26 M ¥
Hwabao WP Fund Management Co., Ltd. 1.352 %	7,957,082	1.352 %	21 M ¥
Hunan Saint-Victorian Management Consulting Center LP 1.286 %	7,567,086	1.286 %	20 M ¥
Hunan Saint Vivianing Management Consulting Center LP 1.235 %	7,267,492	1.235 %	19 M ¥
Yuxiao Liu 1.088 %	6,399,634	1.088 %	17 M ¥
China Cinda Asset Management Co., Ltd. (Investment Company) 0.7545 %	4,440,000	0.7545 %	12 M ¥

Name	Equities	%	Valuation
SANSURE BIOTECH INC. 1.67%	9,835,793	1.67%	26,265,207 $

Sansure Biotech, Inc.

680 Lusong Road High-Tech Industrial Dev Zone

410205, Changsha

http://www.sansure.com.cn

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
SANSURE BIOTECH INC.	-2.46%	1.51B
BIOMÉRIEUX	+0.99%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-15.61%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances